AI Service Squads Build Custom Agentic Solutions That Support Healthcare Organizations As Their Needs Evolve SANTA BARBARA, Calif., May 7, 2026 /PRNewswire/ -- Artera.io, combining human and AI agent ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will be featured in new data presented at the 2026 American Society for Radiation ...

California-based Artera, an agentic AI company that aims to help healthcare providers with patient communication, announced today the appointment of Damon Lanphear as its new chief technology officer.

Artera.io, combining human and AI agent intelligence to fix patient communications, recently announced a $65 million growth investment and a major milestone of reaching $100 million in Contracted ...

Artera Enrolls First Patient in DIRECT-AI Registry, Marking Milestone in Real-World Evidence Generation for AI-Powered Prostate Cancer Care First nationwide study of its kind will evaluate how the ...

Colorectal cancer has a 90%+ survival rate if caught early, but one-third of eligible adults remain unscreened. The primary culprit is the complex, multi-day preparation process, which frequently ...

Colorectal cancer remains a formidable challenge in American healthcare, projected to claim over 55,000 lives in 2026 1. While early-stage detection boasts a survival rate exceeding 90 percent 2, a ...

SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the clinical availability of the ...

SANTA BARBARA, Calif., May 7, 2026 /PRNewswire/ -- Artera.io, combining human and AI agent intelligence to fix the patient experience, today unveiled its AI Services Model for Specialty Care, FQHCs ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the enrollment of the first patient in its DIRECT-AI registry study, ...